Summary: The immediate haemodynamic effects of peruvoside, a cardiac glycoside obtained from the Indian plant Thevetia neriifolia Juss, were studied in six patients with congestive heart failure. The drug was found to have an immediate and powerful positive inotropic and negative chronotropic effect, like ouabain, on the failing human heart. Oral peruvoside was also effective in the treatment of congestive heart failure when used on a short-term as well as a long-term basis. It therefore seems that peruvoside is a useful cardiac glycoside in the management of congestive heart failure in man as a quick-acting intravenous preparation. It is equally effective when used orally. Introduction Peruvoside, a cardiac glycoside isolated by Rangaswami and Rao (1959) from the kernels of the Indian indigenous plant Thevetia neriifolia Juss, is stated to have a positive inotropic effect in the cat papillary muscle (De et al., 1963) , guinea-pig heart (Kohli and Vohra, 1960) , and the failing heart of mongrel * Associate Professor of Cardiology. dogs (Arora et al., 1967) . Studies in congestive heart failure in man are, however, not available. In this communication we outline the haemodynamic effects of intracardiac peruvoside in six patients with heart failure of varying aetiology. We also report our observations on the clinical response to oral peruvoside in these six and in an additional 22 patients treated for 2 to 54 weeks.
Patients and Methods
The six patients (two men and four women) with heart failure, physiologically studied, were aged 30 to 60 years. Congestive heart failure was due to coronary heart disease and primary myocardial disease in two patients each and to atrial septal defect and rheumatic mitral incompetence in one patient each. Three patients were in atrial fibrillation at the time of study. Patients were studied within 48 hours of admission. The investigative nature of the treatment was explained to each patient and consent obtained before the study. Any patient who had received a digitalis preparation in the preceding seven days was excluded from the study. Right heart catheterization was carried out in the postabsorptive resting state in the supine position with standard techniques. The brachial artery was cannulated for 'continuous monitoring of arterial pressure and. as a site for sampling blood-dye mixture for recording indicator dilution curves.
Pressures were recorded through Statham strain gauge pressure transducers of P23 AA series on a multichannel photographic recorder (Electronics for Medicine Inc.). The baseline for all pressure measurements was taken as half the chest thickness at the second costal cartilage with the patient supine (Roy et al., 1957) . Indicator dilution curves were obtained through a continuously recording densitometer (Gilford Inc.) following injection of indocyanine green dye into the pulmonary artery. Cardiac output was calculated from these curves by the technique of Hamilton et al. (1932) . The rate of change of brachial arterial pressure (dp/dt) was recorded with an R.C. differentiator (Electronics for Medicine Inc.).
After obtaining the control data 0-6 to 0-9 
Results

Haemodynamic Studies
Heart Rate, Cardiac Index, and Stroke Index.-As shown in the Table and Fig. 1 the heart rate slowed in all patients (average 36%, range 15 to 58%). Cardiac index increased in all instances though a pronounced increase (32%, 40%, 132%) was seen in only three patients. A consistent and marked increase of stroke index, however, was invariable (average 96%, range 50 to 282%). The increased values for cardiac and stroke indices did not exceed the upper limit of the normal data for our laboratory (Roy et al., 1963) .
Right Atrial Mean Pressures ( were also reduced at the end of 30 minutes by 9 mm. Hg. In only one patient, however, did the pressure become normal, while in others it was still slightly raised. Pulmonary vascular arteriolar resistance was lowered in five patients; in the sixth, where pulmonary arterial wedge pressure could not be obtained, the total pulmonary vascular resistance decreased from 9 to 6.2 units. Except in one instance (Case 1), the calculated resistance was still higher than normal.
Peripheral Arterial Pressure and Vascular Resistance (Table, Fig. 2 ).-Systolic, diastolic, and mean peripheral arterial pressure increased in five of the six patients at 30 minutes after injection of peruvoside. Calculated peripheral vascular resistance was variably altered. It decreased in three patients, and in two of these (Cases 1 and 4) the change was quite marked. In both patients the cardiac indices had increased considerably following peruvoside therapy. In the other three patients vascular resistance increased, but a significant rise was observed in only one (Case 6).
Calculated Values of Cardiac Contractility (Table, Fig. 3 ). -All measures of cardiac contractility calculated from the recorded data showed significant improvement. Thus the left ventricular systolic work, left ventricular stroke work, left ventricular stroke power, systolic ejection rate, and brachial artery dp/dt increased by 52-5%, 120%, 110%, 69.5%, and 6450°,' respectively, while the systolic ejection period decreased by 44%. A plot of mean puhnonary artery wedge pressure and left ventricular external stroke work index (Fig.  4 ) also showed a significant improvement in myocardial contractility, with a leftward shift of the curve on which the left ventricle functioned.
Statistical Analysis
As shown in the Table, all the haemodynamic values when subjected to statistical analysis, except brachial artery mean pressure and the pulmonary and systemic vascular resistances, showed highly significant P values.
Clinical Response to Peruvoside
Heart rate decreased in 20 of the 28 patients and remained virtually unchanged in six patients (less than 15%) who were in normal sinus rhythm. Heart rate reduction was greater in patients with atrial fibrillation (40.9%,') than in those in normal sinus rhythm (20-5%). In two patients with atrial fibrillation of recent onset the cardiac rhythm became normal sinus while the patients were still being treated with peruvoside, and in one patient with intermittent left bundle-branch block the electrocardiogram remained normal during the course of the therapy. De et al. (1963) , and Arora et al. (1967) showed that peruvoside exerted a marked positive inotropic effect in the normal and failing heart and that the drug was quick-acting and as potent as ouabainL Similar data in congestive heart failure in man are not available. This may in part be due to non-availability of the pure glycoside. The present haemodynamic studies support the observations made in experimental animals, and show that peruvoside possesses a marked positive inotropic and negative chronotropic activity in congestive heart failure of varying aetiology in man. It reduced heart rate and increased cardiac and stroke indices, left ventricular work index and left ventricular stroke work index, stroke power, brachial artery dp/dt, and systolic ejection rate, while reducing pulmonary arterial, and reflected left and right atrial pressures, and systolic ejection period. Peruvoside treatment thus resulted in improved myocardial function at lowered left atrial mean pressure, a leftward shift of the ventricular function curve at which the heart operated, an action similar to that of other digitalis preparations (Braunwaid et al., 1965 (Arora et al., 1967) in a small number of patients and by others (Dalal et al., 1970) showed the usefulness of peruvoside in effective management of most patients with congestive heart failure. Trials in the present group of 28 patients likewise showed beneficial effects with this therapy, without significant short-term or long-term sideeffects, except those reversible effects expected with digitalis therapy. Probably the great advantage of peruvoside is its quick ouabain-like action when given intravenously and its oral effectiveness when used on a short-term or long-term basis.
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